InsidersTradesSigma
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Discover the full record of transactions filed by Libby Peter, Director. Insider active across 1 company, notably XBiotech Inc.. Aggregated, 2 disclosures have been recorded. History available since 9 July 2021. The latest transaction was disclosed on 9 July 2021 (Levée d'options). Regulator: SEC (Form 4). The full history is openly available.
2 of 2 declarations
Peter Libby is a director at XBiotech Inc. In this role, he is involved in overseeing the company's activities and making strategic decisions. His experience is valuable for developing biopharmaceutical solutions.